A short review on the current understanding of autism spectrum disorders

Experimental Neurobiology

Volumn 25, Issue 1, 2016, Pages 1-13

  Park, Hye Ran ^a   Lee, Jae Meen ^a   Moon, Hyo Eun ^a   Lee, Dong Soo ^b   Kim, Bung Nyun ^b   Kim, Jinhyun ^c   Kim, Dong Gyu ^a   Paek, Sun Ha ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Amygdala; Autistic Disorders; Neurobiology; Review

Indexed keywords

EID: 84995691257     PISSN: 12262560     EISSN: 20938144     Source Type: Journal    
DOI: 10.5607/en.2016.25.1.1     Document Type: Review

References (152)

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. 3rd ed. American Psychiatric Association, Arlington, VA.
2. Mattila ML, Kielinen M, Linna SL, Jussila K, Ebeling H, Bloigu R, Joseph RM, Moilanen I. (2011) Autism spectrum disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: an epidemiological study. J Am Acad Child Adolesc Psychiatry 50:583-592.e11.
3. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR (2011) Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry 168:904-912.
4. Fisch GS (2012) Nosology and epidemiology in autism: classification counts. Am J Med Genet C Semin Med Genet 160C:91-103.
5. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcín C, Montiel-Nava C, Patel V, Paula CS, Wang C, Yasamy MT, Fombonne E (2012) Global prevalence of autism and other pervasive developmental disorders. Autism Res 5:160-179.
6. Fombonne E (2011) Incidence and prevalence of pervasive developmental disorders. In: Textbook of autism spectrum disorders (Hollander E, Kolevzon A, Coyle JT, eds), pp 117-136 American Psychiatric Publishing, Inc., Washington, D.C.
7. Saemundsen E, Ludvigsson P, Rafnsson V (2007) Autism spectrum disorders in children with a history of infantile spasms: a population-based study. J Child Neurol 22:1102-1107.
8. Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R (2011) Why are autism spectrum conditions more prevalent in males? PLoS Biol 9:e1001081.
9. Robinson EB, Lichtenstein P, Anckarsäter H, Happé F, Ronald A (2013) Examining and interpreting the female protective effect against autistic behavior. Proc Natl Acad Sci U S A 110:5258-5262.
10. Bleuler E (1912) The theory of schizophrenic negativism. The Journal of Nervous and Mental Disease Publishing Company, New York, NY.
11. Asperger H (1944) Die "Autistischen Psychopathen" im Kindesalter. Arch Psychiatr Nervenkr 117:76-136.
12. Kanner L (1943) Autistic disturbances of affective contact. Nerv Child 2:217-250.
13. American Psychiatric Publishing (2013) Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. American Psychiatric Publishing, Arlington, VA.
14. Sinha S, McGovern RA, Sheth SA (2015) Deep brain stimulation for severe autism: from pathophysiology to procedure. Neurosurg Focus 38:E3.
15. Banerjee S, Riordan M, Bhat MA (2014) Genetic aspects of autism spectrum disorders: insights from animal models. Front Cell Neurosci 8:58.
16. Ecker C, Bookheimer SY, Murphy DG (2015) Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol 14:1121-1134.
17. Herman GE, Henninger N, Ratliff-Schaub K, Pastore M, Fitzgerald S, McBride KL (2007) Genetic testing in autism: how much is enough? Genet Med 9:268-274.
18. Miles JH (2011) Autism spectrum disorders-a genetics review. Genet Med 13:278-294.
19. Szatmari P, Jones MB, Zwaigenbaum L, MacLean JE (1998) Genetics of autism: overview and new directions. J Autism Dev Disord 28:351-368.
20. Chang J, Gilman SR, Chiang AH, Sanders SJ, Vitkup D (2015) Genotype to phenotype relationships in autism spectrum disorders. Nat Neurosci 18:191-198.
21. Geschwind DH (2011) Genetics of autism spectrum disorders. Trends Cogn Sci 15:409-416.
22. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH (2011) Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380-384.
23. Clifford S, Dissanayake C, Bui QM, Huggins R, Taylor AK, Loesch DZ (2007) Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord 37:738-747.
24. Curatolo P, Bombardieri R (2008) Tuberous sclerosis. Handb Clin Neurol 87:129-151.
25. Wassink TH, Brzustowicz LM, Bartlett CW, Szatmari P (2004) The search for autism disease genes. Ment Retard Dev Disabil Res Rev 10:272-283.
26. Xu J, Zwaigenbaum L, Szatmari P, Scherer SW (2004) Molecular cytogenetics of autism. Curr Genomics 5:347-364.
27. Dykens EM, Sutcliffe JS, Levitt P (2004) Autism and 15q11-q13 disorders: behavioral, genetic, and pathophysiological issues. Ment Retard Dev Disabil Res Rev 10:284-291.
28. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ; Autism Consortium (2008) Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358:667-675.
29. Casas KA, Mononen TK, Mikail CN, Hassed SJ, Li S, Mulvihill JJ, Lin HJ, Falk RE (2004) Chromosome 2q terminal deletion: report of 6 new patients and review of phenotype-breakpoint correlations in 66 individuals. Am J Med Genet A 130A:331-339.
30. Manzi B, Loizzo AL, Giana G, Curatolo P (2008) Autism and metabolic diseases. J Child Neurol 23:307-314.
31. Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH (2004) Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry 9:474-484.
32. London EA, Etzel RA (2000) The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect 108 Suppl 3:401-404.
33. Kern JK, Jones AM (2006) Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 9:485-499.
34. Kolevzon A, Gross R, Reichenberg A (2007) Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med 161:326-333.
35. Ashwood P, Van de Water J (2004) Is autism an autoimmune disease? Autoimmun Rev 3:557-562.
36. Davidson PW, Myers GJ, Weiss B (2004) Mercury exposure and child development outcomes. Pediatrics 113:1023-1029.
37. Kim YS, Leventhal BL (2015) Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders. Biol Psychiatry 77:66-74.
38. Fombonne E (2005) The epidemiology of pervasive developmental disorders. In: Recent developments in autism research (Casanova MF, ed), pp 1-25. Nova Science Publishers Inc., New York, NY.
39. World Health Organization (2004) International statistical classification of diseases and related health problems. 10th ed. World Health Organization, Geneva.
40. Zwaigenbaum L, Bryson S, Rogers T, Roberts W, Brian J, Szatmari P (2005) Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci 23:143-152.
41. Aggleton JP (1992) The functional effects of amygdala lesions in humans: a comparison with findings from monkeys. In: The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction (Aggleton JP, ed), pp 485-503. Wiley-Liss, New York, NY.
42. Sah P, Faber ES, Lopez De Armentia M, Power J (2003) The amygdaloid complex: anatomy and physiology. Physiol Rev 83:803-834.
43. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381.
44. Lai MC, Lombardo MV, Baron-Cohen S (2014) Autism. Lancet 383:896-910.
45. Adolphs R, Gosselin F, Buchanan TW, Tranel D, Schyns P, Damasio AR (2005) A mechanism for impaired fear recognition after amygdala damage. Nature 433:68-72.
46. Adolphs R, Tranel D, Buchanan TW (2005.) Amygdala damage impairs emotional memory for gist but not details of complex stimuli. Nat Neurosci 8:512-518.
47. Spezio ML, Huang PY, Castelli F, Adolphs R (2007) Amygdala damage impairs eye contact during conversations with real people. J Neurosci 27:3994-3997.
48. Adolphs R (2010) What does the amygdala contribute to social cognition? Ann N Y Acad Sci 1191:42-61.
49. Rolls ET (1992) Neurophysiology and functions of the primate amygdala. In: The amygdala (Aggleton JP, ed), pp 143-165. Wiley-Liss, New York, NY.
50. Brothers L, Ring B, Kling A (1990) Response of neurons in the macaque amygdala to complex social stimuli. Behav Brain Res 41:199-213.
51. Veinante P, Yalcin I, Barrot M (2013) The amygdala between sensation and affect: a role in pain. J Mol Psychiatry 1:9.
52. Nolte J (2002) The human brain: an introduction to its functional anatomy. 5th ed. Mosby, St. Louis, MO.
53. Luczywek E, Mempel E (1976) Stereotactic amygdalotomy in the light of neuropsychological investigations. Acta Neurochir (Wien) 23:221-223.
54. Mempel E, Witkiewicz B, Stadnicki R, Luczywek E, Kucinski L, Pawlowski G, Nowak J (1980) The effect of medial amygdalotomy and anterior hippocampotomy on behavior and seizures in epileptic patients. Acta Neurochir Suppl (Wien) 30:161-7.
55. Narabayashi H, Nagao T, Saito Y, Yoshida M, Nagahata M (1963) Stereotaxic amygdalotomy for behavior disorders. Arch Neurol 9:1-16.
56. Narabayashi H, Uno M (1966) Long range results of stereotaxic amygdalotomy for behavior disorders. Confin Neurol 27:168-171.
57. Bauman ML, Kemper TL (2005) The neurobiology of autism. 2nd ed. The Johns Hopkins University Press, Baltimore, MD.
58. Rapin I, Katzman R (1998) Neurobiology of autism. Ann Neurol 43:7-14.
59. Kemper TL, Bauman M (1998) Neuropathology of infantile autism. J Neuropathol Exp Neurol 57:645-652.
60. Sajdyk TJ, Shekhar A (1997.) Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by γ-aminobutyric acidA receptor blockade in the basolateral amygdala of rats. J Pharmacol Exp Ther 283:969-977.
61. Emery NJ, Clayton NS (2001) Effects of experience and social context on prospective caching strategies by scrub jays. Nature 414:443-446.
62. Sweeten TL, Posey DJ, Shekhar A, McDougle CJ (2002) The amygdala and related structures in the pathophysiology of autism. Pharmacol Biochem Behav 71:449-455.
63. Klüver H, Bucy PC (1939) Preliminary analysis of functions of the temporal lobes in monkeys. Arch Neurol Psychiatry 42:979-1000.
64. Hetzler BE, Griffin JL (1981) Infantile autism and the temporal lobe of the brain. J Autism Dev Disord 11:317-330.
65. Sajdyk TJ, Shekhar A (2000) Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala. Eur J Pharmacol 394:265-273.
66. Adolphs R, Tranel D, Damasio H, Damasio A (1994) Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 372:669-672.
67. Young AW, Hellawell DJ, Van De Wal C, Johnson M (1996) Facial expression processing after amygdalotomy. Neuropsychologia 34:31-39.
68. Stone V (2000) The role of the frontal lobes and the amygdala in theory of mind. In: Understanding other minds: perspectives from autism. 2nd ed. (Baron-Cohen S, Tager-Flusberg H, Cohen DJ, eds), pp 253-273. Oxford University Press, Oxford.
69. Adolphs R, Sears L, Piven J (2001) Abnormal processing of social information from faces in autism. J Cogn Neurosci 13:232-240.
70. Felix-Ortiz AC, Tye KM (2014) Amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior. J Neurosci 34:586-595.
71. Taylor DC, Neville BG, Cross JH (1999) Autistic spectrum disorders in childhood epilepsy surgery candidates. Eur Child Adolesc Psychiatry 8:189-192.
72. Hoon AH Jr, Reiss AL Jr (1992) The mesial-temporal lobe and autism: case report and review. Dev Med Child Neurol 34:252-259.
73. Bolton PF, Griffiths PD (1997) Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349:392-395.
74. Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, Bienstock CA, Hollander E (2000) Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry 157:1994-2001.
75. Courchesne E, Press GA, Yeung-Courchesne R (1993) Parietal lobe abnormalities detected with MR in patients with infantile autism. AJR Am J Roentgenol 160:387-393.
76. Nowell MA, Hackney DB, Muraki AS, Coleman M (1990) Varied MR appearance of autism: fifty-three pediatric patients having the full autistic syndrome. Magn Reson Imaging 8:811-816.
77. Howard MA, Cowell PE, Boucher J, Broks P, Mayes A, Farrant A, Roberts N (2000) Convergent neuroanatomical and behavioural evidence of an amygdala hypothesis of autism. Neuroreport 11:2931-2935.
78. Abell F, Krams M, Ashburner J, Passingham R, Friston K, Frackowiak R, Happé F, Frith C, Frith U (1999) The neuroanatomy of autism: a voxel-based whole brain analysis of structural scans. Neuroreport 10:1647-1651.
79. Ohnishi T, Matsuda H, Hashimoto T, Kunihiro T, Nishikawa M, Uema T, Sasaki M (2000) Abnormal regional cerebral blood flow in childhood autism. Brain 123:1838-1844.
80. Otsuka H, Harada M, Mori K, Hisaoka S, Nishitani H (1999) Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study. Neuroradiology 41:517-519.
81. Stuss DT, Knight RT (2013) Principles of frontal lobe function. Oxford University Press, Oxford.
82. Herbert MR, Ziegler DA, Makris N, Filipek PA, Kemper TL, Normandin JJ, Sanders HA, Kennedy DN, Caviness VS Jr (2004) Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 55:530-540.
83. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, Barnes CC, Pierce K (2011) Neuron number and size in prefrontal cortex of children with autism. JAMA 306:2001-2010.
84. Preuss TM (1995) Do rats have prefrontal cortex? The Rose-Woolsey-Akert program reconsidered. J Cogn Neurosci 7:1-24.
85. Finger S (1994) Origins of neuroscience: a history of explorations into brain function. Oxford University Press, New York, NY.
86. Zelazo PD, Müller U (2002) Chapter 20. Executive function in typical and atypical development. In: Blackwell handbook of childhood cognitive development (Goswami U, ed), pp 445-469. Blackwell Publishers Ltd., Malden, MA.
87. Alvarez JA, Emory E (2006) Executive function and the frontal lobes: a meta-analytic review. Neuropsychol Rev 16:17-42.
88. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267-287.
89. Heidbreder CA, Groenewegen HJ (2003) The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27:555-579.
90. Kim MJ, Whalen PJ (2009) The structural integrity of an amygdala-prefrontal pathway predicts trait anxiety. J Neurosci 29:11614-11618.
91. Wood JN, Grafman J (2003) Human prefrontal cortex: processing and representational perspectives. Nat Rev Neurosci 4:139-147.
92. Frith CD, Frith U (2006) The neural basis of mentalizing. Neuron 50:531-534.
93. Quirk GJ, Mueller D (2008) Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33:56-72.
94. Sotres-Bayon F, Quirk GJ (2010) Prefrontal control of fear: more than just extinction. Curr Opin Neurobiol 20:231-235.
95. Bishop SJ (2007) Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn Sci 11:307-316.
96. Quirk GJ, Beer JS (2006) Prefrontal involvement in the regulation of emotion: convergence of rat and human studies. Curr Opin Neurobiol 16:723-727.
97. Fuchs RA, Eaddy JL, Su ZI, Bell GH (2007) Interactions of the basolateral amygdala with the dorsal hippocampus and dorsomedial prefrontal cortex regulate drug context-induced reinstatement of cocaine-seeking in rats. Eur J Neurosci 26:487-498.
98. Mashhoon Y, Wells AM, Kantak KM (2010) Interaction of the rostral basolateral amygdala and prelimbic prefrontal cortex in regulating reinstatement of cocaine-seeking behavior. Pharmacol Biochem Behav 96:347-353.
99. Cohen MX, Axmacher N, Lenartz D, Elger CE, Sturm V, Schlaepfer TE (2009) Neuroelectric signatures of reward learning and decision-making in the human nucleus accumbens. Neuropsychopharmacology 34:1649-1658.
100. Knutson B, Adams CM, Fong GW, Hommer D (2001) Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21:RC159.
101. Ernst M, Nelson EE, McClure EB, Monk CS, Munson S, Eshel N, Zarahn E, Leibenluft E, Zametkin A, Towbin K, Blair J, Charney D, Pine DS (2004) Choice selection and reward anticipation: an fMRI study. Neuropsychologia 42:1585-1597.
102. Wacker J, Dillon DG, Pizzagalli DA (2009) The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. Neuroimage 46:327-337.
103. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, Joe AY, Kreft M, Lenartz D, Sturm V (2008) Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33:368-377.
104. Schmitz N, Rubia K, van Amelsvoort T, Daly E, Smith A, Murphy DG (2008) Neural correlates of reward in autism. Br J Psychiatry 192:19-24.
105. Scott-Van Zeeland AA, Dapretto M, Ghahremani DG, Poldrack RA, Bookheimer SY (2010) Reward processing in autism. Autism Res 3:53-67.
106. Knutson B, Cooper JC (2005) Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 18:411-417.
107. Kim H, Shimojo S, O'Doherty JP (2006) Is avoiding an aversive outcome rewarding? Neural substrates of avoidance learning in the human brain. PLoS Biol 4:e233.
108. Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA, Dahl RE (2009) Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 166:64-73.
109. Posey DJ, McDougle CJ (2001) Pharmacotherapeutic management of autism. Expert Opin Pharmacother 2:587-600.
110. Adler BA, Wink LK, Early M, Shaffer R, Minshawi N, McDougle CJ, Erickson CA (2015) Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study. Autism 19:102-106.
111. Stigler KA, McDonald BC, Anand A, Saykin AJ, McDougle CJ (2011) Structural and functional magnetic resonance imaging of autism spectrum disorders. Brain Res 1380:146-161.
112. Farmer C, Thurm A, Grant P (2013) Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs 73:303-314.
113. Kerbeshian J, Burd L, Avery K (2001) Pharmacotherapy of autism: A review and clinical approach. J Dev Phys Disabil 13:199-228.
114. McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J (2011) A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127:e1312-e1321.
115. Richards C, Oliver C, Nelson L, Moss J (2012) Self-injurious behaviour in individuals with autism spectrum disorder and intellectual disability. J Intellect Disabil Res 56:476-489.
116. Odom SL, Boyd BA, Hall LJ, Hume K (2010) Evaluation of comprehensive treatment models for individuals with autism spectrum disorders. J Autism Dev Disord 40:425-436.
117. Benabid AL (2003) Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol 13:696-706.
118. Lozano AM, Dostrovsky J, Chen R, Ashby P (2002) Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol 1:225-231.
119. Hamani C, Pilitsis J, Rughani AI, Rosenow JM, Patil PG, Slavin KS, Abosch A, Eskandar E, Mitchell LS, Kalkanis S; American Society for Stereotactic and Functional Neurosurgery; Congress of Neurological Surgeons; CNS and American Association of Neurological Surgeons (2014) Deep brain stimulation for obsessive-compulsive disorder: systematic review and evidence-based guideline sponsored by the American Society for Stereotactic and Functional Neurosurgery and the Congress of Neurological Surgeons (CNS) and endorsed by the CNS and American Association of Neurological Surgeons. Neurosurgery 75:327-333.
120. Taghva AS, Malone DA, Rezai AR (2013) Deep brain stimulation for treatment-resistant depression. World Neurosurg 80:S27.e17-S27.e24.
121. Schrock LE, Mink JW, Woods DW, Porta M, Servello D, Visser-Vandewalle V, Silburn PA, Foltynie T, Walker HC, Shahed-Jimenez J, Savica R, Klassen BT, Machado AG, Foote KD, Zhang JG, Hu W, Ackermans L, Temel Y, Mari Z, Changizi BK, Lozano A, Auyeung M, Kaido T, Agid Y, Welter ML, Khandhar SM, Mogilner AY, Pourfar MH, Walter BL, Juncos JL, Gross RE, Kuhn J, Leckman JF, Neimat JA, Okun MS; Tourette Syndrome Association International Deep Brain Stimulation (DBS) Database and Registry Study Group (2015) Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord 30:448-471.
122. Sturm V, Fricke O, Bührle CP, Lenartz D, Maarouf M, Treuer H, Mai JK, Lehmkuhl G (2012) DBS in the basolateral amygdala improves symptoms of autism and related self-injurious behavior: a case report and hypothesis on the pathogenesis of the disorder. Front Hum Neurosci 6:341.
123. Stocco A, Baizabal-Carvallo JF (2014) Deep brain stimulation for severe secondary stereotypies. Parkinsonism Relat Disord 20:1035-1036.
124. Helsmoortel C, Vulto-van Silfhout AT, Coe BP, Vandeweyer G, Rooms L, van den Ende J, Schuurs-Hoeijmakers JH, Marcelis CL, Willemsen MH, Vissers LE, Yntema HG, Bakshi M, Wilson M, Witherspoon KT, Malmgren H, Nordgren A, Annerén G, Fichera M, Bosco P, Romano C, de Vries BB, Kleefstra T, Kooy RF, Eichler EE, Van der Aa N (2014) A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat Genet 46:380-384.
125. Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, Reilly SK, Lin L, Fertuzinhos S, Miller JA, Murtha MT, Bichsel C, Niu W, Cotney J, Ercan-Sencicek AG, Gockley J, Gupta AR, Han W, He X, Hoffman EJ, Klei L, Lei J, Liu W, Liu L, Lu C, Xu X, Zhu Y, Mane SM, Lein ES, Wei L, Noonan JP, Roeder K, Devlin B, Sestan N, State MW (2013) Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155:997-1007.
126. Halgren C, Kjaergaard S, Bak M, Hansen C, El-Schich Z, Anderson CM, Henriksen KF, Hjalgrim H, Kirchhoff M, Bijlsma EK, Nielsen M, den Hollander NS, Ruivenkamp CA, Isidor B, Le Caignec C, Zannolli R, Mucciolo M, Renieri A, Mari F, Anderlid BM, Andrieux J, Dieux A, Tommerup N, Bache I (2012) Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B. Clin Genet 82:248-255.
127. Cotney J, Muhle RA, Sanders SJ, Liu L, Willsey AJ, Niu W, Liu W, Klei L, Lei J, Yin J, Reilly SK, Tebbenkamp AT, Bichsel C, Pletikos M, Sestan N, Roeder K, State MW, Devlin B, Noonan JP (2015) The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat Commun 6:6404.
128. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, Singh T, Klei L, Kosmicki J, Shih-Chen F, Aleksic B, Biscaldi M, Bolton PF, Brownfeld JM, Cai J, Campbell NG, Carracedo A, Chahrour MH, Chiocchetti AG, Coon H, Crawford EL, Curran SR, Dawson G, Duketis E, Fernandez BA, Gallagher L, Geller E, Guter SJ, Hill RS, Ionita-Laza J, Jimenz Gonzalez P, Kilpinen H, Klauck SM, Kolevzon A, Lee I, Lei I, Lei J, Lehtimäki T, Lin CF, Ma'ayan A, Marshall CR, McInnes AL, Neale B, Owen MJ, Ozaki N, Parellada M, Parr JR, Purcell S, Puura K, Rajagopalan D, Rehnström K, Reichenberg A, Sabo A, Sachse M, Sanders SJ, Schafer C, Schulte-Rüther M, Skuse D, Stevens C, Szatmari P, Tammimies K, Valladares O, Voran A, Li-San W, Weiss LA, Willsey AJ, Yu TW, Yuen RK, Cook EH, Freitag CM, Gill M, Hultman CM, Lehner T, Palotie A, Schellenberg GD, Sklar P, State MW, Sutcliffe JS, Walsh CA, Scherer SW, Zwick ME, Barett JC, Cutler DJ, Roeder K, Devlin B, Daly MJ, Buxbaum JDDDD StudyHomozygosity Mapping Collaborative for Autism; UK10K Consortium (2014) Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515:209-215.
129. Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O, Witherspoon K, Gerdts J, Baker C, Vulto-van Silfhout AT, Schuurs-Hoeijmakers JH, Fichera M, Bosco P, Buono S, Alberti A, Failla P, Peeters H, Steyaert J, Vissers LE, Francescatto L, Mefford HC, Rosenfeld JA, Bakken T, O'Roak BJ, Pawlus M, Moon R, Shendure J, Amaral DG, Lein E, Rankin J, Romano C, de Vries BB, Katsanis N, Eichler EE (2014) Disruptive CHD8 mutations define a subtype of autism early in development. Cell 158:263-276.
130. Van Bon BW, Coe BP, Bernier R, Green C, Gerdts J, Witherspoon K, Kleefstra T, Willemsen MH, Kumar R, Bosco P, Fichera M, Li D, Amaral D, Cristofoli F, Peeters H, Haan E, Romano C, Mefford HC, Scheffer I, Gecz J, de Vries BB, Eichler EE (2016) Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol Psychiatry 21:126-132. PubMed
131. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485:246-250.
132. Murdoch JD, State MW (2013) Recent developments in the genetics of autism spectrum disorders. Curr Opin Genet Dev 23:310-315.
133. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C (2005) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42:318-321.
134. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, El-Fishawy P, Murtha RC, Choi M, Overton JD, Bjornson RD, Carriero NJ, Meyer KA, Bilguvar K, Mane SM, Sestan N, Lifton RP, Günel M, Roeder K, Geschwind DH, Devlin B, State MW (2012) De novo mutations revealed by wholeexome sequencing are strongly associated with autism. Nature 485:237-241.
135. Grozeva D, Carss K, Spasic-Boskovic O, Parker MJ, Archer H, Firth HV, Park SM, Canham N, Holder SE, Wilson M, Hackett A, Field M, Floyd JA, Hurles M, Raymond FL; UK10K Consortium (2014) De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability. Am J Hum Genet 94:618-624.
136. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsäter H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Rogé B, Héron D, Burglen L, Gillberg C, Leboyer M, B ourgeron T (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39:25-27.
137. Willsey AJ, State MW (2015) Autism spectrum disorders: from genes to neurobiology. Curr Opin Neurobiol 30:92-99.
138. Hamdan FF, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs MO, Joober R, Lacaille JC, Nadeau A, Milunsky JM, Wang Z, Carmant L, Mottron L, Beauchamp MH, Rouleau GA, Michaud JL (2011) De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry 69:898-901.
139. Deriziotis P, O'Roak BJ, Graham SA, Estruch SB, Dimitropoulou D, Bernier RA, Gerdts J, Shendure J, Eichler EE, Fisher SE (2014) De novo TBR1 mutations in sporadic autism disrupt protein functions. Nat Commun 5:4954.
140. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, Patterson PH, Shi L, Sidwell R (2002) Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22:25-33.
141. Fatemi SH, Pearce DA, Brooks AI, Sidwell RW (2005) Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 57:91-99.
142. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS (2005) Autistic disorder and viral infections. J Neurovirol 11:1-10.
143. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347:1477-1482.
144. Yasuda H, Yoshida K, Yasuda Y, Tsutsui T (2011) Infantile zinc deficiency: association with autism spectrum disorders. Sci Rep 1:129.
145. Grabrucker S, Jannetti L, Eckert M, Gaub S, Chhabra R, et al. (2014) Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders. Brain 137:137-152.
146. Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsäter H, Rastam M, Ståhlberg O, Gillberg IC, Delorme R, Chabane N, Mouren-Simeoni MC, Fauchereau F, Durand CM, Chevalier F, Drouot X, Collet C, Launay JM, Leboyer M, Gillberg C, Bourgeron T (2008) Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 13:90-98.
147. Rossignol DA, Frye RE (2011) Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 53:783-792.
148. Tanne JH (2012) Maternal obesity and diabetes are linked to children's autism and similar disorders. BMJ 344:e2768.
149. Kinney DK, Munir KM, Crowley DJ, Miller AM (2008) Prenatal stress and risk for autism. Neurosci Biobehav Rev 32:1519-1532.
150. Miyazaki K, Narita N, Narita M (2005) Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int J Dev Neurosci 23:287-297.
151. Eskenazi B, Marks AR, Bradman A, Harley K, Barr DB, Johnson C, Morga N, Jewell NP (2007) Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 115:792-798.
152. Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E, Schendel D, Thorsen P, Mortensen PB (2005) Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol 161:916-925.